Nikko Asset Management Americas, Inc. Soma Logic, Inc. Transaction History

Nikko Asset Management Americas, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$1.76 - $2.83 $818,972 - $1.32 Million	-465,325 Reduced 5.31%	8,302,035 $21 Million
Q3 2023 Nov 09, 2023	BUY	$1.99 - $2.45 $51,586 - $63,511	25,923 Added 0.3%	8,767,360 $21 Million
Q2 2023 Aug 14, 2023	BUY	$2.1 - $3.36 $9.26 Million - $14.8 Million	4,411,248 Added 101.87%	8,741,437 $20.2 Million
Q1 2023 May 03, 2023	SELL	$2.13 - $3.6 $246,357 - $416,379	-115,661 Reduced 2.6%	4,330,189 $11 Million
Q4 2022 Feb 13, 2023	BUY	$2.05 - $3.47 $76,889 - $130,149	37,507 Added 0.85%	4,445,850 $11.2 Million

Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $1.53 Million - $13.3 Million	2,434,400 Added 123.33%	4,408,343 $11.4 Million
Q2 2022 Aug 04, 2022	BUY	$4.27 - $8.26 $4.27 Million - $8.26 Million	999,698 Added 102.61%	1,973,943 $7.9 Million
Q1 2022 May 06, 2022	SELL	$7.07 - $11.62 $552,379 - $907,870	-78,130 Reduced 7.42%	974,245 $7.02 Million
Q4 2021 Feb 08, 2022	BUY	$10.49 - $14.28 $9.27 Million - $12.6 Million	883,494 Added 523.15%	1,052,375 $12.2 Million
Q3 2021 Nov 09, 2021	BUY	$9.94 - $12.77 $1.68 Million - $2.16 Million	168,881 New	168,881 $1.86 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.